tiprankstipranks
Hua Medicine Ltd. (HK:2552)
:2552

Compare Hua Medicine (2552) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Hua Medicine
HK$3.29
HK$3.55B
2.54
76.47%
HUTCHMED (China)
HK$21.18
HK$20.52B
4.97
9.58%
10 Buy
0 Hold
1 Sell
Strong Buy
Livzon Pharmaceutical Group
HK$30.94
HK$31.87B
11.61
9.46%
0 Buy
0 Hold
1 Sell
Moderate Sell
China Resources Pharmaceutical Group Ltd.
HK$4.61
HK$39.83B
6.37
26.68%
5 Buy
0 Hold
0 Sell
Strong Buy
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.19
HK$17.24B
19.65
15.44%
Hansoh Pharmaceutical Group Company Limited
HK$38.46
HK$234.70B
35.71
70.18%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2552
Hua Medicine
3.60
1.56
76.47%
HK:0013
HUTCHMED (China)
23.56
0.56
2.43%
HK:1513
Livzon Pharmaceutical Group
28.24
3.00
11.89%
HK:3320
China Resources Pharmaceutical Group Ltd.
6.22
1.34
27.33%
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
5.01
0.83
19.86%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.46
15.91
70.55%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts